NO20055582L - Preparater og fremgangsmater omfattende gastrinforbindelser - Google Patents

Preparater og fremgangsmater omfattende gastrinforbindelser

Info

Publication number
NO20055582L
NO20055582L NO20055582A NO20055582A NO20055582L NO 20055582 L NO20055582 L NO 20055582L NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 L NO20055582 L NO 20055582L
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
beneficial effects
gastrin
Prior art date
Application number
NO20055582A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055582D0 (no
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/no
Publication of NO20055582L publication Critical patent/NO20055582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20055582A 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser NO20055582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 NO20055582D0 (no) 2005-11-25
NO20055582L true NO20055582L (no) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (no) 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser

Country Status (11)

Country Link
EP (1) EP1648495A2 (pt)
JP (1) JP2007513059A (pt)
CN (1) CN1829528A (pt)
AU (1) AU2004243541A1 (pt)
BR (1) BRPI0410710A (pt)
CA (1) CA2527186A1 (pt)
MX (1) MXPA05012605A (pt)
NO (1) NO20055582L (pt)
PL (1) PL379145A1 (pt)
RU (1) RU2005140518A (pt)
WO (1) WO2004105780A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1486204A (zh) 2001-01-12 2004-03-31 ������˹ҩƷ��˾ 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物
DE60329724D1 (de) 2002-06-07 2009-11-26 Waratah Pharmaceuticals Inc Methoden und Kompositionen um Diabetes zu behandeln
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
WO2005072045A2 (en) * 2004-01-30 2005-08-11 Waratah Pharmaceuticals, Inc. The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1132091A1 (en) * 1994-01-24 2001-09-12 The General Hospital Corporation Treatment for diabetes
CN1486204A (zh) * 2001-01-12 2004-03-31 ������˹ҩƷ��˾ 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物
AU2003283004A1 (en) * 2002-10-22 2004-05-13 Waratah Pharmaceuticals, Inc. Treatment of diabetes

Also Published As

Publication number Publication date
RU2005140518A (ru) 2007-07-10
NO20055582D0 (no) 2005-11-25
WO2004105780A2 (en) 2004-12-09
CN1829528A (zh) 2006-09-06
AU2004243541A1 (en) 2004-12-09
PL379145A1 (pl) 2006-07-24
WO2004105780A3 (en) 2005-01-20
BRPI0410710A (pt) 2006-06-13
JP2007513059A (ja) 2007-05-24
EP1648495A2 (en) 2006-04-26
MXPA05012605A (es) 2006-02-22
CA2527186A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
ATE484508T1 (de) Furylverbindungen
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
MX2007005933A (es) Compuestos de acetamida como fungicidas.
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
MX2007005408A (es) Compuestos de aminoquinazolinas.
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
ATE477256T1 (de) Thienylverbindungen
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
MXPA05011962A (es) Oxiarenos substituidos.
IN2012DN02609A (pt)
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE50309647D1 (de) Ng fibrotischer erkrankungen
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
DK1638948T3 (da) Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application